Inter Pharma PCL (BKK:IP)

Inter Pharma PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	184.6	412.39	776.42	173.87	152.33
Short-Term Investments	0.93	0.86	0.83	0.8	0.77
Cash & Short-Term Investments	185.53	413.25	777.25	174.67	153.09
Cash Growth	-55.10%	-46.83%	344.99%	14.09%	-55.35%
Accounts Receivable	376.06	337.32	340.3	258.11	124.38
Other Receivables	71.37	87.74	51.89	34.08	31.49
Receivables	447.43	425.06	392.2	292.25	155.93
Inventory	339.49	351.82	332.98	192	107.65
Other Current Assets	9.35	12.72	12.78	7.7	0.61
Total Current Assets	981.8	1,203	1,515	666.61	417.28
Property, Plant & Equipment	1,150	929.27	880.77	457.32	255.39
Long-Term Investments	134.04	43.37	9.35	10.12	-
Goodwill	477.85	477.85	477.85	22.16	22.16
Other Intangible Assets	204.46	197.36	167.79	55.1	48.58
Long-Term Deferred Tax Assets	20.17	15.91	9.81	8.98	3.38
Other Long-Term Assets	52.16	85.75	29.52	106.76	9.5
Total Assets	3,021	2,952	3,090	1,327	756.33
Accounts Payable	184.6	200.52	193.79	69.65	58.49
Accrued Expenses	46.03	47.06	34.74	15.92	11.69
Short-Term Debt	79.91	46.34	48.73	131.01	11.01
Current Portion of Long-Term Debt	55.2	54.43	72.51	35.62	15.53
Current Portion of Leases	26.64	38.89	30.46	0.57	0.64
Current Income Taxes Payable	11.84	4.11	25.18	14.8	8.4
Current Unearned Revenue	4.59	-	-	-	-
Other Current Liabilities	117.47	87.39	92.55	68.06	54.58
Total Current Liabilities	526.29	478.75	497.95	335.63	160.35
Long-Term Debt	167.19	205.46	319.61	187.06	90.91
Long-Term Leases	65.5	54.83	67.69	1.9	2.47
Long-Term Deferred Tax Liabilities	58.22	59.21	55.33	3.53	7.62
Other Long-Term Liabilities	8.32	3.66	2.14	-	-
Total Liabilities	866.4	834.65	973.86	543.54	269.89
Common Stock	302.67	186.26	186.26	149.01	103
Additional Paid-In Capital	1,498	1,498	1,498	492.09	304.98
Retained Earnings	132.41	225.25	238.26	116.85	58.16
Comprehensive Income & Other	3.7	3.7	3.7	3.7	3.7
Total Common Equity	1,937	1,913	1,926	761.64	469.85
Minority Interest	217.4	204.53	190.25	21.86	16.59
Shareholders' Equity	2,154	2,118	2,116	783.5	486.44
Total Liabilities & Equity	3,021	2,952	3,090	1,327	756.33
Total Debt	394.45	399.95	539	356.17	120.57
Net Cash (Debt)	-208.92	13.3	238.25	-181.5	32.53
Net Cash Growth	-	-94.42%	-	-	-90.25%
Net Cash Per Share	-0.35	0.02	0.45	-0.38	0.07
Filing Date Shares Outstanding	605.34	605.35	605.35	484.27	468.65
Total Common Shares Outstanding	605.34	605.35	605.35	484.27	468.65
Working Capital	455.51	724.1	1,017	330.98	256.93
Book Value Per Share	3.20	3.16	3.18	1.57	1.00
Tangible Book Value	1,254	1,238	1,281	684.38	399.11
Tangible Book Value Per Share	2.07	2.05	2.12	1.41	0.85
Land	333.9	327.63	327.63	183.25	117.3
Buildings	534.98	430.08	404.55	177.13	66.64
Machinery	379.84	346.66	310.51	148.3	105.7
Construction In Progress	174.85	57.17	15.97	0.33	1.1

Source: S&P Capital IQ. Standard template. Financial Sources.